Loxo Oncology, Inc.
Pharmaceutical company · Stamford, Connecticut, United States
Loxo Oncology, Inc. is a pharmaceutical company headquartered in Stamford, Connecticut, United States. Its earliest recorded incorporation is in 2013. It has reported private securities offerings to the US SEC, most recently $24 million sold in a notice filed in 2014.
Loxo Oncology at a glance
What does Loxo Oncology do?
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $23.9 million sold (2014).
Frequently asked questions about Loxo Oncology
Where is Loxo Oncology headquartered?
Loxo Oncology, Inc. is headquartered in Stamford, Connecticut, United States.
What does Loxo Oncology do?
Loxo Oncology, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
When was Loxo Oncology founded?
The earliest incorporation on record for Loxo Oncology, Inc. is in 2013, according to public company registers.
Similar companies
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
- Karyopharm Therapeutics Inc.Newton, Massachusetts, United States
- Dare Bioscience, Inc.San Diego, California, United States
- Cellectar Biosciences, Inc.Florham Park, New Jersey, United States
- Marker Therapeutics, Inc.Houston, Texas, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.